Dichlormezanone

This classification denotes a sedative and hypnotic with the molecular formula C11H11Cl2NO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TO4OC41XVI, chemically known as 4-metathiazanone, 2-(3,4-dichlorophenyl)-3-methyl-, 1,1-dioxide but generally known as dichlormezanone, which bears US NIH Compound Identifier 71209. European Medicines Agency schedules Dichlormezanone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07084MIG. The term DICHLORMEZANONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). DICHLORMEZANONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dichlormezanone under HS 29349990 and SITC 51579. As of Q4 2014, DICHLORMEZANONE remains the US FDA Preferred Term for this commodity. Dichlormezanone bears US NLM identifiers UMLS ID C2699629 and NCI Concept Code C77250. SMILES: CN1C(S(=O)(=O)CCC1=O)C2=CC(=C(C=C2)CL)CL.